Stoke Therapeutics, Inc.·4

Jul 2, 4:08 PM ET

LEVIN ARTHUR A 4

4 · Stoke Therapeutics, Inc. · Filed Jul 2, 2025

Insider Transaction Report

Form 4
Period: 2025-06-30
Transactions
  • Exercise/Conversion

    Restricted Stock Units

    2025-06-301,2102,422 total
    Exp: 2025-12-31Common Stock (1,210 underlying)
  • Exercise/Conversion

    Common Stock

    2025-06-30+1,2102,420 total
Holdings
  • Common Stock

    (indirect: By Trust)
    17,979
Footnotes (2)
  • [F1]Each Restricted Stock Unit represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement.
  • [F2]The award vested or vests as to 1/4 of the total award quarterly on the last day of March, June, September, and December, subject to the reporting person's continued service to the issuer through each vesting date.

Documents

1 file
  • 4
    form4-07022025_080722.xmlPrimary